Ticagrelor-induced thrombotic thrombocytopenic purpura: A case report and review of the literature

RATIONALE: Ticagrelor, a new type of P2Y(12) receptor antagonist, has been highly recommended to be used in acute coronary syndrome by the latest guideline, but its side effects are not well-known. We seek to illustrate a potential fatal condition, thrombotic thrombocytopenic purpura (TTP), caused b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoya, Zhang, Shufang, Li, Leiqing, Hua, Junjie, Zhu, Lei, Li, Libin, Zhang, Gensheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039671/
https://www.ncbi.nlm.nih.gov/pubmed/29952973
http://dx.doi.org/10.1097/MD.0000000000011206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039671/
https://www.ncbi.nlm.nih.gov/pubmed/29952973
http://dx.doi.org/10.1097/MD.0000000000011206

Ejemplares similares